Table of Content

1 Anti-PD-1 Antibody Market Overview
1.1 Product Overview and Scope of Anti-PD-1 Antibody
1.2 Anti-PD-1 Antibody Segment by Type
1.2.1 Global Anti-PD-1 Antibody Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Anti-PD-1 Antibody Segment by Application
1.3.1 Anti-PD-1 Antibody Sales Comparison by Application: (2021-2027)
1.3.2 IHC-P
1.3.3 ICC/IF
1.3.4 WB
1.3.5 Flow Cytometry
1.3.6 ELISA
1.4 Global Anti-PD-1 Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-PD-1 Antibody Revenue 2016-2027
1.4.2 Global Anti-PD-1 Antibody Sales 2016-2027
1.4.3 Anti-PD-1 Antibody Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anti-PD-1 Antibody Market Competition by Manufacturers
2.1 Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-PD-1 Antibody Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-PD-1 Antibody Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-PD-1 Antibody Manufacturing Sites, Area Served, Product Type
2.5 Anti-PD-1 Antibody Market Competitive Situation and Trends
2.5.1 Anti-PD-1 Antibody Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-PD-1 Antibody Players Market Share by Revenue
2.5.3 Global Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-PD-1 Antibody Retrospective Market Scenario by Region
3.1 Global Anti-PD-1 Antibody Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-PD-1 Antibody Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-PD-1 Antibody Market Facts & Figures by Country
3.3.1 North America Anti-PD-1 Antibody Sales by Country
3.3.2 North America Anti-PD-1 Antibody Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-PD-1 Antibody Market Facts & Figures by Country
3.4.1 Europe Anti-PD-1 Antibody Sales by Country
3.4.2 Europe Anti-PD-1 Antibody Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-PD-1 Antibody Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-PD-1 Antibody Sales by Region
3.5.2 Asia Pacific Anti-PD-1 Antibody Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-PD-1 Antibody Market Facts & Figures by Country
3.6.1 Latin America Anti-PD-1 Antibody Sales by Country
3.6.2 Latin America Anti-PD-1 Antibody Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-PD-1 Antibody Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-PD-1 Antibody Sales by Country
3.7.2 Middle East and Africa Anti-PD-1 Antibody Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-PD-1 Antibody Historic Market Analysis by Type
4.1 Global Anti-PD-1 Antibody Sales Market Share by Type (2016-2021)
4.2 Global Anti-PD-1 Antibody Revenue Market Share by Type (2016-2021)
4.3 Global Anti-PD-1 Antibody Price by Type (2016-2021)

5 Global Anti-PD-1 Antibody Historic Market Analysis by Application
5.1 Global Anti-PD-1 Antibody Sales Market Share by Application (2016-2021)
5.2 Global Anti-PD-1 Antibody Revenue Market Share by Application (2016-2021)
5.3 Global Anti-PD-1 Antibody Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bio X Cell
6.1.1 Bio X Cell Corporation Information
6.1.2 Bio X Cell Description and Business Overview
6.1.3 Bio X Cell Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bio X Cell Product Portfolio
6.1.5 Bio X Cell Recent Developments/Updates
6.2 Thermo Fisher
6.2.1 Thermo Fisher Corporation Information
6.2.2 Thermo Fisher Description and Business Overview
6.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Thermo Fisher Product Portfolio
6.2.5 Thermo Fisher Recent Developments/Updates
6.3 InvivoGen
6.3.1 InvivoGen Corporation Information
6.3.2 InvivoGen Description and Business Overview
6.3.3 InvivoGen Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.3.4 InvivoGen Product Portfolio
6.3.5 InvivoGen Recent Developments/Updates
6.4 BioVision Inc
6.4.1 BioVision Inc Corporation Information
6.4.2 BioVision Inc Description and Business Overview
6.4.3 BioVision Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BioVision Inc Product Portfolio
6.4.5 BioVision Inc Recent Developments/Updates
6.5 Abcam
6.5.1 Abcam Corporation Information
6.5.2 Abcam Description and Business Overview
6.5.3 Abcam Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Abcam Product Portfolio
6.5.5 Abcam Recent Developments/Updates
6.6 Bristol-Myers Squibb (BMS)
6.6.1 Bristol-Myers Squibb (BMS) Corporation Information
6.6.2 Bristol-Myers Squibb (BMS) Description and Business Overview
6.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bristol-Myers Squibb (BMS) Product Portfolio
6.6.5 Bristol-Myers Squibb (BMS) Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Ono Pharmaceutical Co., Ltd
6.8.1 Ono Pharmaceutical Co., Ltd Corporation Information
6.8.2 Ono Pharmaceutical Co., Ltd Description and Business Overview
6.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ono Pharmaceutical Co., Ltd Product Portfolio
6.8.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Lilly Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Chugai Pharmaceutical Co., Ltd
6.10.1 Chugai Pharmaceutical Co., Ltd Corporation Information
6.10.2 Chugai Pharmaceutical Co., Ltd Description and Business Overview
6.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Chugai Pharmaceutical Co., Ltd Product Portfolio
6.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
6.11 BeiGene
6.11.1 BeiGene Corporation Information
6.11.2 BeiGene Anti-PD-1 Antibody Description and Business Overview
6.11.3 BeiGene Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.11.4 BeiGene Product Portfolio
6.11.5 BeiGene Recent Developments/Updates
6.12 Abbvie
6.12.1 Abbvie Corporation Information
6.12.2 Abbvie Anti-PD-1 Antibody Description and Business Overview
6.12.3 Abbvie Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Abbvie Product Portfolio
6.12.5 Abbvie Recent Developments/Updates
6.13 TG Therapeutics, Inc
6.13.1 TG Therapeutics, Inc Corporation Information
6.13.2 TG Therapeutics, Inc Anti-PD-1 Antibody Description and Business Overview
6.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.13.4 TG Therapeutics, Inc Product Portfolio
6.13.5 TG Therapeutics, Inc Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Corporation Information
6.14.2 Novartis Anti-PD-1 Antibody Description and Business Overview
6.14.3 Novartis Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Novartis Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Arcus Biosciences
6.15.1 Arcus Biosciences Corporation Information
6.15.2 Arcus Biosciences Anti-PD-1 Antibody Description and Business Overview
6.15.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Arcus Biosciences Product Portfolio
6.15.5 Arcus Biosciences Recent Developments/Updates
6.16 Sino Biological Inc
6.16.1 Sino Biological Inc Corporation Information
6.16.2 Sino Biological Inc Anti-PD-1 Antibody Description and Business Overview
6.16.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Sino Biological Inc Product Portfolio
6.16.5 Sino Biological Inc Recent Developments/Updates
6.17 3SBio Inc
6.17.1 3SBio Inc Corporation Information
6.17.2 3SBio Inc Anti-PD-1 Antibody Description and Business Overview
6.17.3 3SBio Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2016-2021)
6.17.4 3SBio Inc Product Portfolio
6.17.5 3SBio Inc Recent Developments/Updates

7 Anti-PD-1 Antibody Manufacturing Cost Analysis
7.1 Anti-PD-1 Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-PD-1 Antibody
7.4 Anti-PD-1 Antibody Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-PD-1 Antibody Distributors List
8.3 Anti-PD-1 Antibody Customers

9 Anti-PD-1 Antibody Market Dynamics
9.1 Anti-PD-1 Antibody Industry Trends
9.2 Anti-PD-1 Antibody Growth Drivers
9.3 Anti-PD-1 Antibody Market Challenges
9.4 Anti-PD-1 Antibody Market Restraints

10 Global Market Forecast
10.1 Anti-PD-1 Antibody Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-PD-1 Antibody by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-PD-1 Antibody by Type (2022-2027)
10.2 Anti-PD-1 Antibody Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-PD-1 Antibody by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-PD-1 Antibody by Application (2022-2027)
10.3 Anti-PD-1 Antibody Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-PD-1 Antibody by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-PD-1 Antibody by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-PD-1 Antibody Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-PD-1 Antibody Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Anti-PD-1 Antibody Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-PD-1 Antibody Covered in This Study
Table 5. Global Anti-PD-1 Antibody Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Anti-PD-1 Antibody Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-PD-1 Antibody Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-PD-1 Antibody Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-PD-1 Antibody Average Price (USD/g) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-PD-1 Antibody Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-PD-1 Antibody Product Type
Table 12. Global Anti-PD-1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-PD-1 Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-PD-1 Antibody as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-PD-1 Antibody Sales by Region (2016-2021) & (Kg)
Table 16. Global Anti-PD-1 Antibody Sales Market Share by Region (2016-2021)
Table 17. Global Anti-PD-1 Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-PD-1 Antibody Sales by Country (2016-2021) & (Kg)
Table 19. North America Anti-PD-1 Antibody Sales Market Share by Country (2016-2021)
Table 20. North America Anti-PD-1 Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-PD-1 Antibody Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-PD-1 Antibody Sales by Country (2016-2021) & (Kg)
Table 23. Europe Anti-PD-1 Antibody Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-PD-1 Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-PD-1 Antibody Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-PD-1 Antibody Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-PD-1 Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-PD-1 Antibody Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-PD-1 Antibody Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Anti-PD-1 Antibody Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-PD-1 Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-PD-1 Antibody Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-PD-1 Antibody Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-PD-1 Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-PD-1 Antibody Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-PD-1 Antibody Sales (Kg) by Type (2016-2021)
Table 39. Global Anti-PD-1 Antibody Sales Market Share by Type (2016-2021)
Table 40. Global Anti-PD-1 Antibody Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-PD-1 Antibody Revenue Share by Type (2016-2021)
Table 42. Global Anti-PD-1 Antibody Price (USD/g) by Type (2016-2021)
Table 43. Global Anti-PD-1 Antibody Sales (Kg) by Application (2016-2021)
Table 44. Global Anti-PD-1 Antibody Sales Market Share by Application (2016-2021)
Table 45. Global Anti-PD-1 Antibody Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-PD-1 Antibody Revenue Share by Application (2016-2021)
Table 47. Global Anti-PD-1 Antibody Price (USD/g) by Application (2016-2021)
Table 48. Bio X Cell Corporation Information
Table 49. Bio X Cell Description and Business Overview
Table 50. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 51. Bio X Cell Anti-PD-1 Antibody Product
Table 52. Bio X Cell Recent Developments/Updates
Table 53. Thermo Fisher Corporation Information
Table 54. Thermo Fisher Description and Business Overview
Table 55. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 56. Thermo Fisher Anti-PD-1 Antibody Product
Table 57. Thermo Fisher Recent Developments/Updates
Table 58. InvivoGen Corporation Information
Table 59. InvivoGen Description and Business Overview
Table 60. InvivoGen Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 61. InvivoGen Anti-PD-1 Antibody Product
Table 62. InvivoGen Recent Developments/Updates
Table 63. BioVision Inc Corporation Information
Table 64. BioVision Inc Description and Business Overview
Table 65. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 66. BioVision Inc Anti-PD-1 Antibody Product
Table 67. BioVision Inc Recent Developments/Updates
Table 68. Abcam Corporation Information
Table 69. Abcam Description and Business Overview
Table 70. Abcam Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 71. Abcam Anti-PD-1 Antibody Product
Table 72. Abcam Recent Developments/Updates
Table 73. Bristol-Myers Squibb (BMS) Corporation Information
Table 74. Bristol-Myers Squibb (BMS) Description and Business Overview
Table 75. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 76. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product
Table 77. Bristol-Myers Squibb (BMS) Recent Developments/Updates
Table 78. Merck Corporation Information
Table 79. Merck Description and Business Overview
Table 80. Merck Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 81. Merck Anti-PD-1 Antibody Product
Table 82. Merck Recent Developments/Updates
Table 83. Ono Pharmaceutical Co., Ltd Corporation Information
Table 84. Ono Pharmaceutical Co., Ltd Description and Business Overview
Table 85. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 86. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product
Table 87. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 88. Lilly Corporation Information
Table 89. Lilly Description and Business Overview
Table 90. Lilly Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 91. Lilly Anti-PD-1 Antibody Product
Table 92. Lilly Recent Developments/Updates
Table 93. Chugai Pharmaceutical Co., Ltd Corporation Information
Table 94. Chugai Pharmaceutical Co., Ltd Description and Business Overview
Table 95. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 96. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product
Table 97. Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 98. BeiGene Corporation Information
Table 99. BeiGene Description and Business Overview
Table 100. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 101. BeiGene Anti-PD-1 Antibody Product
Table 102. BeiGene Recent Developments/Updates
Table 103. Abbvie Corporation Information
Table 104. Abbvie Description and Business Overview
Table 105. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 106. Abbvie Anti-PD-1 Antibody Product
Table 107. Abbvie Recent Developments/Updates
Table 108. TG Therapeutics, Inc Corporation Information
Table 109. TG Therapeutics, Inc Description and Business Overview
Table 110. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 111. TG Therapeutics, Inc Anti-PD-1 Antibody Product
Table 112. TG Therapeutics, Inc Recent Developments/Updates
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Business Overview
Table 115. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 116. Novartis Anti-PD-1 Antibody Product
Table 117. Novartis Recent Developments/Updates
Table 118. Arcus Biosciences Corporation Information
Table 119. Arcus Biosciences Description and Business Overview
Table 120. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 121. Arcus Biosciences Anti-PD-1 Antibody Product
Table 122. Arcus Biosciences Recent Developments/Updates
Table 123. Sino Biological Inc Corporation Information
Table 124. Sino Biological Inc Description and Business Overview
Table 125. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 126. Sino Biological Inc Anti-PD-1 Antibody Product
Table 127. Sino Biological Inc Recent Developments/Updates
Table 128. 3SBio Inc Corporation Information
Table 129. 3SBio Inc Description and Business Overview
Table 130. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 131. 3SBio Inc Anti-PD-1 Antibody Product
Table 132. 3SBio Inc Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Anti-PD-1 Antibody Distributors List
Table 136. Anti-PD-1 Antibody Customers List
Table 137. Anti-PD-1 Antibody Market Trends
Table 138. Anti-PD-1 Antibody Growth Drivers
Table 139. Anti-PD-1 Antibody Market Restraints
Table 140. Global Anti-PD-1 Antibody Sales Forecast by Type (2022-2027) & (Kg)
Table 141. Global Anti-PD-1 Antibody Sales Market Share Forecast by Type (2022-2027)
Table 142. Global Anti-PD-1 Antibody Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 143. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Type (2022-2027)
Table 144. Global Anti-PD-1 Antibody Sales Forecast by Application (2022-2027) & (Kg)
Table 145. Global Anti-PD-1 Antibody Sales Market Share Forecast by Application (2022-2027)
Table 146. Global Anti-PD-1 Antibody Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 147. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Application (2022-2027)
Table 148. Global Anti-PD-1 Antibody Sales Forecast by Region (2022-2027) & (Kg)
Table 149. Global Anti-PD-1 Antibody Sales Market Share Forecast by Region (2022-2027)
Table 150. Global Anti-PD-1 Antibody Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 151. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Region (2022-2027)
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-PD-1 Antibody
Figure 2. Global Anti-PD-1 Antibody Market Share by Type in 2020 & 2027
Figure 3. Monoclonal Product Picture
Figure 4. Polyclonal Product Picture
Figure 5. Global Anti-PD-1 Antibody Market Share by Application in 2020 & 2027
Figure 6. IHC-P
Figure 7. ICC/IF
Figure 8. WB
Figure 9. Flow Cytometry
Figure 10. ELISA
Figure 11. Global Anti-PD-1 Antibody Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anti-PD-1 Antibody Market Size 2016-2027 (US$ Million)
Figure 13. Global Anti-PD-1 Antibody Sales 2016-2027 (Kg)
Figure 14. Global Anti-PD-1 Antibody Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Anti-PD-1 Antibody Sales Share by Manufacturers in 2020
Figure 16. Global Anti-PD-1 Antibody Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Anti-PD-1 Antibody Players: Market Share by Revenue in 2020
Figure 18. Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Anti-PD-1 Antibody Sales Market Share by Region (2016-2021)
Figure 20. Global Anti-PD-1 Antibody Sales Market Share by Region in 2020
Figure 21. Global Anti-PD-1 Antibody Revenue Market Share by Region (2016-2021)
Figure 22. Global Anti-PD-1 Antibody Revenue Market Share by Region in 2020
Figure 23. U.S. Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Anti-PD-1 Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Anti-PD-1 Antibody by Type (2016-2021)
Figure 48. Sales Market Share of Anti-PD-1 Antibody by Application (2016-2021)
Figure 49. Sales Market Share of Anti-PD-1 Antibody by Application in 2020
Figure 50. Revenue Share of Anti-PD-1 Antibody by Application (2016-2021)
Figure 51. Revenue Share of Anti-PD-1 Antibody by Application in 2020
Figure 52. Manufacturing Cost Structure of Anti-PD-1 Antibody
Figure 53. Manufacturing Process Analysis of Anti-PD-1 Antibody
Figure 54. Anti-PD-1 Antibody Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed